SAN DIEGO— Entest BioMedical, a company developing an immunotherapeutic cancer treatment for dogs, signed a letter of intent to buy
three veterinary hospitals in Orange County.
The company reports the acquisition will generate about $900,000 in new revenue and will help the company execute on its strategic
goal of creating a network of animal hospitals, In January, the company closed on the purchase of Santa Barbara's McDonald
Animal Hospital. These acquisitions are estimated at bringing Entest revenues of about $2 million a year in the veterinary
"Initially, Entest plans on focusing on veterinary acquisition candidates in California, with future plans to expand into
other states," company officials say.
Last November, Entest unveiled a safety study for an immunotherapeutic cancer vaccine for dogs currently in development. Entest
also initiated a collaboration with RenovoCyte LLC and Medistem Inc. to explore the development of a stem-cell therapy for
treating hip dysplasia in dogs.